SCOPUS 정보 검색 플랫폼

Journal of Neuro-Oncology

Volumn 105, Issue 2, 2011, Pages 397-400

Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma

(2) Marucci, Gianluca a Morandi, Luca a

a UNIVERSITY OF BOLOGNA (Italy)

Author keywords

Anaplastic; MGMT; Pleomorphic xanthoastrocytoma; Temozolomide

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN REGION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG USE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATIENT ASSESSMENT; PLEOMORPHIC XANTHOASTROCYTOMA; PROMOTER REGION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 82955233457 PISSN: 0167594X EISSN: 15737373 Source Type: Journal
DOI: 10.1007/s11060-011-0605-6 Document Type: Article

Times cited : (18)

References (9)

1
- 34347269034
- IARC Press Lyon
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) World Health Organization classification of tumours of the central nervous system. IARC Press, Lyon
- (2007) World Health Organization Classification of Tumours of the Central Nervous System
- Louis, D.N.¹ Ohgaki, H.² Wiestler, O.D.³ Cavenee, W.K.⁴

2
- 0033135352
- Pleomorphic xanthoastrocytoma: What do we really know about it
- DOI 10.1002/(SICI)1097-0142(19990501)85:9<2033::AID-CNCR22>3.0. CO;2-Z
- C Giannini BW Scheithauer PC Burger, et al. 1999 Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 85 2033 2045 10223246 1:STN:280:DyaK1M3jslOmtQ%3D%3D (Pubitemid 29202780)
- (1999) Cancer , vol.85 , Issue.9 , pp. 2033-2045
- Giannini, C.¹ Scheithauer, B.W.² Burger, P.C.³ Brat, D.J.⁴ Wollan, P.C.⁵ Lach, B.⁶ O'Neill, B.P.⁷

3
- 0029887716
- Pleomorphic xanthoastrocytoma: Case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis
- 8692406 10.1227/00006123-199604000-00038 1:STN:280:DyaK283kslygug%3D%3D
- PA Pahapill DA Ramsay RF Del Maestro 1996 Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis Neurosurgery 38 822 828 8692406 10.1227/00006123-199604000-00038 1:STN:280:DyaK283kslygug%3D%3D
- (1996) Neurosurgery , vol.38 , pp. 822-828
- Pahapill, P.A.¹ Ramsay, D.A.² Del Maestro, R.F.³

4
- 77956251759
- Malignant progression of a pleomorphic xanthoastrocytoma in a child
- 20799153 10.1055/s-0030-1255094 1:STN:280:DC%2BC3cjptlSqsQ%3D%3D
- GA Alexiou M Moschovi K Stefanaki C Prodromou G Sfakianos N Prodromou 2010 Malignant progression of a pleomorphic xanthoastrocytoma in a child Neuropediatrics 41 69 71 20799153 10.1055/s-0030-1255094 1:STN:280: DC%2BC3cjptlSqsQ%3D%3D
- (2010) Neuropediatrics , vol.41 , pp. 69-71
- Alexiou, G.A.¹ Moschovi, M.² Stefanaki, K.³ Prodromou, C.⁴ Sfakianos, G.⁵ Prodromou, N.⁶

5
- 78651365606
- Anaplastic pleomorphic xanthoastrocytoma with a component of anaplastic astrocytoma presenting as skull base tumor followed by downward extracranial extension
- 10.2176/nmc.50.1108
- S Tsutsumi Y Abe Y Yasumoto M Ito 2010 Anaplastic pleomorphic xanthoastrocytoma with a component of anaplastic astrocytoma presenting as skull base tumor followed by downward extracranial extension Neurol Med Chir 50 1108 1112 10.2176/nmc.50.1108
- (2010) Neurol Med Chir , vol.50 , pp. 1108-1112
- Tsutsumi, S.¹ Abe, Y.² Yasumoto, Y.³ Ito, M.⁴

6
- 20044372154
- MGMT gene silencing and benefit from temozolomide in glioblastoma
- DOI 10.1056/NEJMoa043331
- ME Hegi AC Diserens T Gorlia, et al. 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997 1003 15758010 10.1056/NEJMoa043331 1:CAS:528:DC%2BD2MXit1Wktro%3D (Pubitemid 40349502)
- (2005) New England Journal of Medicine , vol.352 , Issue.10 , pp. 997-1003
- Hegi, M.E.¹ Diserens, A.-C.² Gorlia, T.³ Hamou, M.-F.⁴ De Tribolet, N.⁵ Weller, M.⁶ Kros, J.M.⁷ Hainfellner, J.A.⁸ Mason, W.⁹ Mariani, L.¹⁰ Bromberg, J.E.C.¹¹ Hau, P.¹² Mirimanoff, R.O.¹³ Cairncross, J.G.¹⁴ Janzer, R.C.¹⁵ Stupp, R.¹⁶

7
- 77949460376
- Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: Detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
- 20167086 10.1186/1471-2407-10-48 1:CAS:528:DC%2BC3cXitl2rurw%3D
- L Morandi E Franceschi D de Biase, et al. 2010 Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference BMC Cancer 10 48 20167086 10.1186/1471-2407-10-48 1:CAS:528:DC%2BC3cXitl2rurw%3D
- (2010) BMC Cancer , vol.10 , pp. 48
- Morandi, L.¹ Franceschi, E.² De Biase, D.³

8
- 0035710746
- -ΔΔCT method
- DOI 10.1006/meth.2001.1262
- -ΔΔCt method Methods 25 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528: DC%2BD38XhtFelt7s%3D (Pubitemid 34164012)
- (2001) Methods , vol.25 , Issue.4 , pp. 402-408
- Livak, K.J.¹ Schmittgen, T.D.²

9
- 78149249554
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- 20975057 10.1212/WNL.0b013e3181f96282 1:CAS:528:DC%2BC3cXhtlGmtrjK
- C Houillier X Wang G Kaloshi, et al. 2010 IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas Neurology 75 1560 1566 20975057 10.1212/WNL.0b013e3181f96282 1:CAS:528:DC%2BC3cXhtlGmtrjK
- (2010) Neurology , vol.75 , pp. 1560-1566
- Houillier, C.¹ Wang, X.² Kaloshi, G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.